ABI-1179

· Assembly Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABI-1179, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes [Phase 1]

See pricing